findmyKOL

Smathorn Thakolwiboon, MD

Basic profile

Wheaton Franciscan Healthcare

ORCID↗NPI↗
✓ Full record
RegionLa Crosse, WI · MidwestSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Smathorn Thakolwiboon is a Neurology physician affiliated with Wheaton Franciscan Healthcare. OpenAlex indexes 82 publications with 566 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
82publications

Distinct works indexed by OpenAlex, matched via ORCID.

566citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

800 West Ave S
La Crosse, WI 546018806

Telephone

608-785-0940

Provider last certified this registry record 23 Aug 2023.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    79.9%
    Cholinesterase Inhibitor18%
    Donepezil Hcl70%Rivastigmine31%
    Part D<11 patients
    Potassium Channel Blocker8.4%
    Dalfampridine Er100%
    Part D≥18 patients

    + 17 more classes in this area

  • Musculoskeletal

    9.6%
    gamma-Aminobutyric Acid-ergic Agonist7.8%
    Baclofen100%
    Part D≥20 patients
    Central alpha-2 Adrenergic Agonist1.8%
    Tizanidine Hcl100%
    Part D<11 patients
  • Cancer & immunology

    7.1%
    CD20-directed Cytolytic Antibody2.5%
    Kesimpta Pen100%
    Part D<11 patients
    Sphingosine 1-phosphate Receptor Modulator2.1%
    Fingolimod100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)98.2% facility · 1.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”